Literature DB >> 19425525

Asbestos--a legacy and a persistent problem.

F J H Brims1.   

Abstract

Asbestos has been utilised by industrialised nations for over a century and its deleterious health effects have been reported for an almost equal length of time. Whilst developed countries have now reduced their asbestos use, developing nations are increasing their asbestos imports and consumption. Because of this, there is now a perceived risk to Non Government Organisation and military personnel involved in aid operations or conflict areas, where asbestos containing materials and buildings may have been disrupted. With significant asbestos exposures to U.K. military and dockyard personnel in the past, the health consequences are continuing to increase, with the incidence of malignant mesothelioma expected to continue to rise until between 2012-2020. There is no effective cure or treatment for any of the lung or pleural asbestos related diseases; malignant mesothelioma has a median survival of just 6-12 months. Misconceptions about asbestos are widespread, contributed in part by a long latency between exposure and disease. Following diagnosis of an asbestos related disease, financial recompense for ex-service personnel is limited, and the civilian legal implications continue to change. This review will encompass the historical usage of asbestos, its biological effects, the legal and financial implications of exposure, and establish that there may be a continuing threat of exposure to deployed military personnel

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19425525

Source DB:  PubMed          Journal:  J R Nav Med Serv        ISSN: 0035-9033


  9 in total

1.  miR-1 induces growth arrest and apoptosis in malignant mesothelioma.

Authors:  Yue Xu; Ming Zheng; Robert E Merritt; Joseph B Shrager; Heather A Wakelee; Robert A Kratzke; Chuong D Hoang
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

2.  Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.

Authors:  Giuseppe Matullo; Simonetta Guarrera; Marta Betti; Giovanni Fiorito; Daniela Ferrante; Floriana Voglino; Gemma Cadby; Cornelia Di Gaetano; Fabio Rosa; Alessia Russo; Ari Hirvonen; Elisabetta Casalone; Sara Tunesi; Marina Padoan; Mara Giordano; Anna Aspesi; Caterina Casadio; Francesco Ardissone; Enrico Ruffini; Pier Giacomo Betta; Roberta Libener; Roberto Guaschino; Ezio Piccolini; Monica Neri; Arthur W B Musk; Nicholas H de Klerk; Jennie Hui; John Beilby; Alan L James; Jenette Creaney; Bruce W Robinson; Sutapa Mukherjee; Lyle J Palmer; Dario Mirabelli; Donatella Ugolini; Stefano Bonassi; Corrado Magnani; Irma Dianzani
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  Synchrotron soft X-ray imaging and fluorescence microscopy reveal novel features of asbestos body morphology and composition in human lung tissues.

Authors:  Lorella Pascolo; Alessandra Gianoncelli; Burkhard Kaulich; Clara Rizzardi; Manuela Schneider; Cristina Bottin; Maurizio Polentarutti; Maya Kiskinova; Antonio Longoni; Mauro Melato
Journal:  Part Fibre Toxicol       Date:  2011-02-07       Impact factor: 9.400

4.  Meeting report: mode(s) of action of asbestos and related mineral fibers.

Authors:  Maureen R Gwinn; Danielle DeVoney; Annie M Jarabek; Babasaheb Sonawane; John Wheeler; David N Weissman; Scott Masten; Claudia Thompson
Journal:  Environ Health Perspect       Date:  2011-08-01       Impact factor: 9.031

5.  A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.

Authors:  Samal Gunatilake; Fraser J H Brims; Carole Fogg; Iain Lawrie; Nick Maskell; Karen Forbes; Najib Rahman; Steve Morris; Reuben Ogollah; Stephen Gerry; Mick Peake; Liz Darlison; Anoop J Chauhan
Journal:  Trials       Date:  2014-09-19       Impact factor: 2.279

6.  Developing Asbestos Job Exposure Matrix Using Occupation and Industry Specific Exposure Data (1984-2008) in Republic of Korea.

Authors:  Sangjun Choi; Dongmug Kang; Donguk Park; Hyunhee Lee; Bongkyoo Choi
Journal:  Saf Health Work       Date:  2016-09-29

7.  Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.

Authors:  Sanjeevan Muruganandan; Helman Alfonso; Peter Franklin; Keith Shilkin; Amanda Segal; Nola Olsen; Alison Reid; Nick de Klerk; Aw Bill Musk; Fraser Brims
Journal:  Br J Cancer       Date:  2017-02-14       Impact factor: 7.640

8.  The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy.

Authors:  Lorella Pascolo; Alessandra Gianoncelli; Giulia Schneider; Murielle Salomé; Manuela Schneider; Carla Calligaro; Maya Kiskinova; Mauro Melato; Clara Rizzardi
Journal:  Sci Rep       Date:  2013-01-24       Impact factor: 4.379

9.  Job Exposure Matrix for Chrysotile Asbestos Fibre in the Asbestos Cement Manufacturing (ACM) Industry in Zimbabwe.

Authors:  Benjamin Mutetwa; Dingani Moyo; Derk Brouwer
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.